What is the general market price of Bedaquiline 24 capsules?
The price of Bedaquiline has always been a practical factor that tuberculosis patients and families are highly concerned about, especially among drug-resistant tuberculosis patients who require long-term treatment. Drug affordability directly affects treatment compliance. Judging from the current domestic and foreign market conditions, the price differences between bedaquiline in different regions and different versions are very obvious.
In mainland China, bedaquiline fumarate tablets have been officially launched and included in the medical insurance system, which is an important step in improving its accessibility. The common specifications in China are100mg×24 tablets, and the price per box is about 10,000 yuan. Although the price is still not low, with the support of medical insurance policies, the actual out-of-pocket proportion of patients has been relatively reduced, making it affordable for some families. This price positioning also reflects the R&D and production costs of bedaquiline as an innovative anti-tuberculosis drug.
Looking at overseas markets, the packaging specifications and pricing strategies of bedaquiline are even more different. For example, in countries such as Russia, large format packaging of 100 mg × 188 tablets exists on the market, and the price of the whole box may reach about 14,000 yuan. Since there are more pieces in a single box, from the perspective of "single piece cost", it is not a simple comparison with domestic specifications, but is affected by local policies, procurement models and exchange rates.
At the same time, generic versions of bedaquiline have also appeared overseas, mainly produced by some Indian pharmaceutical companies. These generic drugs are consistent with the original drugs in terms of ingredient design and have obvious price advantages. Taking 188 tablets as an example, its price may be in the range of more than 2,000 yuan, which greatly reduces the cost of treatment. Therefore, it is used in some countries to improve the accessibility of drug-resistant tuberculosis treatment.
Reference materials:https://en.wikipedia.org/wiki/Bedaquiline
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)